Medication therapy management in patients with tuberculosis and HIV/AIDS: case series
Objectives: To describe cases of patients with tuberculosis (TB) and HIV / AIDS coinfection followed up at a Reference Hospital in infectious diseases. Identify, classify, and resolve the Drug Related Problems (DRP). And classify the clinical and pharmacotherapeutical situation. Methods: For the identification, classification, and resolution of the DRP outcome as well as the clinical and pharmacotherapeutical situation, the Pharmacotherapy Workup methodology was used. This is na observational, descriptive, longitudinal, case series study carried out in a tertiary referral hospital in Belo Horizonte, following CARE guidelines endorsed by Enhancing the QUAlity and Transparency Of health Research (EQUATOR) Network. Patients coinfected with TB and HIV/AIDS, exposed to the treatment recommended by the Ministry of Health, aged 18 years or older, of both genders, followed for a minimum period of six months, were included. Results: Six cases of patients co-infected with TB and HIV/AIDS were described. The average number of meetings with the pharmacist was 6.33 (standard deviation=0.82). A total of 69 DRPs were identified, of which 40/69 (58.0%) were related to adherence, 17/69 (24.6%) to the indication, 8/69 (11.6%) to safety and 4/69 (5.8%) to effectiveness. Of the total number of patients 4/6 (66.6%) had hepatotoxicity during follow-up. The clinical and pharmacotherapeutical situation was classified as positive for all patients. Conclusion: There was a high number of adherence and indication DRP in coinfected patients. Monitoring the effectiveness and safety of treatments must be carried out, due to the greater susceptibility to adverse reactions, such as hepatotoxicity.
How to Cite
Copyright (c) 2021 Authors
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
The authors hereby transfer, assign, or otherwise convey to RBFHSS: (1) the right to grant permission to republish or reprint the stated material, in whole or in part, without a fee; (2) the right to print republish copies for free distribution or sale; and (3) the right to republish the stated material in any format (electronic or printed). In addition, the undersigned affirms that the article described above has not previously been published, in whole or part, is not subject to copyright or other rights except by the author(s), and has not been submitted for publication elsewhere, except as communicated in writing to RHFHSS with this document.
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License (CC-BY-NC-ND) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
This journal permits and encourages authors to post and archive the final pdf of the articles submitted to the journal on personal websites or institutional repositories after publication, while providing bibliographic details that credit its publication in this journal.